Jan 24, 2021
This article includes some commonly asked questions about COVID-19 vaccination. CDC also has information for busting common vaccine myths available on facts about…
Jan 10, 2021
Venetoclax is efficacious in relapsed/refractory t(11;14) multiple myeloma, thus warranting investigation in light-chain amyloidosis (AL). This retrospective cohort…
Jan 10, 2021
Background: Despite emerging treatments for hereditary transthyretin (ATTRv) amyloidosis, the disease is often misdiagnosed, with reported diagnostic delays of up…
Jan 06, 2021
The International Society of Amyloidosis (ISA)external link, opens in a new tab developed criteria for assessing the haematologic response to treatment in light…
Jan 06, 2021
Hereditary transthyretin (hATTR) amyloidosis is a rare, systemic, progressive, and life-threatening disease in which transthyretin proteins misfold and aggregate as…
Oct 25, 2020
The ISA Nomenclature Committee met electronically before and directly after the XVII ISA International Symposium on Amyloidosis, which, unfortunately, had to be…
Oct 21, 2020
Finding out you have a rare genetic disease such as familial amyloid polyneuropathy (FAP) can be unsettling, especially if you live alone or planning to do so.…
Sep 22, 2020
Background: Transthyretin amyloidosis (also known as ATTR amyloidosis) is a systemic, life-threatening disease characterized by transthyretin (TTR) fibril…
Sep 13, 2020
Systemic amyloidosis is a rare protein misfolding and deposition disorder leading to progressive organ failure. There are over 15 types of systemic amyloidosis,…
Aug 06, 2020
A series of recent discoveries harnessing the adaptive immune system of prokaryotes to perform targeted genome editing is having a transformative influence across…